Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM)

Objectives In terms of HIV infection, western and central Africa is the second most affected region world‐wide, and the gap between the regional figures for the testing and treatment cascade and the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90–90–90 targets is particularly worrying. We ass...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	HIV medicine 2019-01, Vol.20 (1), p.38-46
Hauptverfasser:	Liégeois, F, Eymard‐Duvernay, S, Maradan, G, Kouanfack, C, Mpoudi‐Ngolé, E, Spire, B, Delaporte, E, Vidal, L, Kuaban, C, Laurent, C, Ambani, A, Ndalle, O, Momo, P, Tong, C, March, L, Mora, M, Sagaon Teyssier, L, e Sèze, M, Suzan Monti, M, Chabrol, F, Kouakam, E, Ossanga, O, Essama Owona, H, Biloa, C, Mengue, M. T, Fouda, P. J, Abessolo, H, Defo, M, Meli, H, Perfura, Y, Ngo Tonye, M, Kouambo, O, Olinga, U, Soh, E, Njom Nlend, E, Simo Ndongo, A, Abeng Mbozo'o, E, Mpoudi Ngole, M, Manga, N, Danwe, C, Ayangma, L, Taman, B, Njitoyap Ndam, E. C, Fangam Molu, B, Meli, J, Hadja, H, Lindou, J, Bob Oyono, J. M, Beke, S, Eloundou, D, Ze, J. J, Fokoua, M, Ngum, L, Ewolo, C, Bondze, C, Maninzou, D. S, Nono Toche, A, Tsoungi Akoa, M, Akoa, P, Abia, S, Guterrez, A, Thumerel, P, Mapoure, Y, Malongue, A, Meledie Ndjong, A. P, Mbatchou, B, Hachu, J, Ngwane, S, Dissongo, J, Penda, I., Mossi, H, Tchatchoua, G, Ngongang, Y., Nouboue, C, Wandji, I, Ndalle, L, Djene, J, Gomez, M. J, Mafuta, A, Mgantcha, M, Moby, E. H, Kuitcheu, M. C, Mawe, A. L, Engonwei, N., Ndam, M, Pallawo, R. B, Adamou, I., Temgoua, G, Ndjie Essaga, C, Ngo, I, Fokam, H, Nyemb, H, Njock, L. R, Omgnesseck, S, Kamto, E, Takou, B, Buffeteau, L. J. G, Ndoumbe, F, Noah, J. D, Seyep, I
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired immune deficiency syndrome Adult Africa AIDS Anti-Retroviral Agents - pharmacology Anti-Retroviral Agents - therapeutic use antiretroviral Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Cameroon - epidemiology CD4 antigen CD4 Lymphocyte Count Confidence intervals Cross-Sectional Studies effectiveness Female Health care Health care facilities Heterogeneity HIV HIV Infections - drug therapy HIV-1 - drug effects HIV-1 - physiology Hospital facilities Hospitals Human health and pathology Human immunodeficiency virus Humans Infectious diseases Life Sciences Littoral environments Male Medication Adherence Middle Aged Patients Pharmaceutical sciences Pharmacology Prevalence Regression analysis Regression models Ribonucleic acid RNA RNA, Viral - drug effects Rural Population Santé publique et épidémiologie Statistical analysis Surveys and Questionnaires Viral Load - drug effects virological outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objectives In terms of HIV infection, western and central Africa is the second most affected region world‐wide, and the gap between the regional figures for the testing and treatment cascade and the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90–90–90 targets is particularly worrying. We assessed the prevalence of virological suppression in patients routinely treated in 19 hospitals in Cameroon. Methods A cross‐sectional survey was performed in adult patients receiving antiretroviral therapy (ART) in the Centre and Littoral regions. The prevalences of virological suppression (
ISSN:	1464-2662 1468-1293
DOI:	10.1111/hiv.12681